title: Gene-gene interaction between CD40 and CD40L reduces bone mineral density and increases osteoporosis risk in women.
abstract: CONCLUSIONS
  We have analysed the association of single-nucleotide polymorphisms (SNPs) in CD40 and CD40L genes with bone mineral density (BMD) in our women. Results showed that women with TT genotype for rs1883832 (CD40) and for rs1126535 (CD40L) SNPs displayed reduced BMD and increased risk for osteopenia/osteoporosis. Our data notwithstanding, the results need to be replicated.
  
  
  BACKGROUND
  Recent data have revealed that the CD40/CD40L system can be implicated in bone metabolism regulation. Moreover, we previously demonstrated that rs1883832 in the CD40 gene was significantly associated with BMD and osteoporosis risk. The objective of the present work was to determine whether polymorphisms in CD40 and CD40L genes are associated with BMD and osteoporosis risk.
  
  
  METHODS
  We conducted an association study of BMD values with SNPs in CD40 and CD40L genes in a population of 811 women of which 693 and 711 had femoral neck (FN) and lumbar spine (LS) densitometric studies, respectively.
  
  
  RESULTS
  Women with the TT genotype for rs1883832 (CD40) showed a reduction in FN-BMD (P = 0.005) and LS-BMD (P = 0.020) when compared with women with the CC/CT genotype. Moreover, we found that rs1126535 (CD40L) was significantly associated with LS-BMD so that women with the TT genotype displayed lower BMD (P = 0.014) than did women with the CC/CT genotype. Interestingly, we have found a strong interaction between polymorphisms in these genes. Thus, women with the TT genotype for both rs1883832 and rs1126535 SNPs (TT + TT women) showed a lower age-adjusted BMD (Z-score) for FN (P = 0.0007) and LS (0.007) after adjusting by years since menopause, body mass index, smoking and menopausal status, densitometer type, hormone replacement therapy (HRT) use and HRT duration and after making the Bonferroni adjustment for multiple comparisons than did the remaining women. Logistic regression analysis adjusted by these covariates showed that TT + TT women had increased risk for FN (odds ratio (OR) = 2.76; P = 0.006) and LS (OR = 2.39; P = 0.020) osteopenia or osteoporosis than did the other women.
  
  
  CONCLUSIONS
  Our results suggest that interaction between genetic variants in the CD40 and CD40L genes exerts a role on BMD regulation. Further studies, which we welcome, are needed to replicate these data in other populations.
authors.affiliation: Research Foundation, Hospital Clínico Universitario, Av. Blasco Ibáñez, 17, 46010 Valencia, Spain.
authors.forename: B
authors.initials: B
authors.lastname: Pineda
authors.forename: J J
authors.initials: JJ
authors.lastname: Tarín
authors.forename: C
authors.initials: C
authors.lastname: Hermenegildo
authors.forename: P
authors.initials: P
authors.lastname: Laporta
authors.forename: A
authors.initials: A
authors.lastname: Cano
authors.forename: M Á
authors.initials: MÁ
authors.lastname: García-Pérez
mesh_terms: D015502:Absorptiometry, Photon / Q000379:methods; D000368:Aged; D000886:Anthropometry / Q000379:methods; D015519:Bone Density / Q000235:genetics; D019013:CD40 Antigens / Q000235:genetics*; D023201:CD40 Ligand / Q000235:genetics*; D005260:Female; D005272:Femur Neck / Q000503:physiopathology; D005787:Gene Frequency; D020022:Genetic Predisposition to Disease; D005838:Genotype; D006801:Humans; D008159:Lumbar Vertebrae / Q000503:physiopathology; D008875:Middle Aged; D015663:Osteoporosis, Postmenopausal / Q000235:genetics* / Q000503:physiopathology; D020641:Polymorphism, Single Nucleotide
chemical_list: D019013:CD40 Antigens; D023201:CD40 Ligand